FYERS
Home
/
Stocks
/
Profit Loss
/
Lincoln Pharmaceuticals Profit & Loss

Lincoln Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012
₹191 Cr₹177 Cr₹187 Cr₹166 Cr₹163 Cr₹154 Cr₹168 Cr₹147 Cr₹161 Cr₹147 Cr₹142 Cr₹146 Cr₹156 Cr₹136 Cr₹112 Cr₹134 Cr₹141 Cr₹123 Cr₹103 Cr₹120 Cr₹127 Cr₹122 Cr₹80 Cr₹115 Cr₹126 Cr₹104 Cr₹78 Cr₹99 Cr₹113 Cr₹97 Cr₹79 Cr₹84 Cr₹103 Cr₹100 Cr₹67 Cr₹80 Cr₹90 Cr₹150 Cr₹121 Cr₹72 Cr₹75 Cr₹89 Cr₹120 Cr₹108 Cr₹95 Cr₹76 Cr₹79 Cr₹68 Cr₹78 Cr₹49 Cr₹67 Cr₹53 Cr₹56 Cr₹40 Cr₹60 Cr₹52 Cr₹55 Cr
₹10 Cr₹24 Cr-₹4 Cr₹15 Cr₹7 Cr₹15 Cr-₹7 Cr₹9 Cr₹10 Cr₹10 Cr₹7 Cr₹11 Cr₹9 Cr₹8 Cr₹4 Cr₹6 Cr₹6 Cr₹6 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹73 L₹60 L₹2 Cr₹4 Cr₹3 Cr₹3 Cr₹1 Cr-₹87 L₹38 L₹4 Cr₹2 Cr₹86 L₹3 Cr₹3 Cr₹3 Cr₹21 L₹3 Cr₹3 Cr₹4 Cr₹9 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹201 Cr₹202 Cr₹183 Cr₹181 Cr₹171 Cr₹169 Cr₹161 Cr₹156 Cr₹171 Cr₹158 Cr₹150 Cr₹157 Cr₹165 Cr₹143 Cr₹116 Cr₹140 Cr₹146 Cr₹130 Cr₹104 Cr₹123 Cr₹131 Cr₹124 Cr₹82 Cr₹115 Cr₹127 Cr₹106 Cr₹83 Cr₹102 Cr₹115 Cr₹98 Cr₹78 Cr₹85 Cr₹107 Cr₹102 Cr₹68 Cr₹83 Cr₹93 Cr₹153 Cr₹121 Cr₹75 Cr₹78 Cr₹93 Cr₹129 Cr₹108 Cr₹95 Cr₹76 Cr₹79 Cr₹68 Cr₹78 Cr₹49 Cr₹67 Cr₹53 Cr₹56 Cr₹40 Cr₹60 Cr₹52 Cr₹55 Cr
₹172 Cr₹154 Cr₹166 Cr₹146 Cr₹142 Cr₹134 Cr₹145 Cr₹126 Cr₹136 Cr₹128 Cr₹127 Cr₹120 Cr₹127 Cr₹117 Cr₹98 Cr₹109 Cr₹114 Cr₹109 Cr₹87 Cr₹99 Cr₹100 Cr₹99 Cr₹66 Cr₹97 Cr₹98 Cr₹84 Cr₹72 Cr₹87 Cr₹90 Cr₹80 Cr₹70 Cr₹73 Cr₹85 Cr₹78 Cr₹59 Cr₹65 Cr₹76 Cr₹145 Cr₹118 Cr₹65 Cr₹65 Cr₹75 Cr₹118 Cr₹96 Cr₹85 Cr₹65 Cr₹72 Cr₹62 Cr₹67 Cr₹43 Cr₹62 Cr₹47 Cr₹51 Cr₹36 Cr₹53 Cr₹49 Cr₹50 Cr
₹33 Cr₹52 Cr₹21 Cr₹39 Cr₹33 Cr₹39 Cr₹20 Cr₹33 Cr₹38 Cr₹33 Cr₹25 Cr₹41 Cr₹40 Cr₹28 Cr₹21 Cr₹33 Cr₹35 Cr₹23 Cr₹19 Cr₹26 Cr₹33 Cr₹27 Cr₹18 Cr₹21 Cr₹30 Cr₹24 Cr₹13 Cr₹16 Cr₹27 Cr₹20 Cr₹10 Cr₹14 Cr₹24 Cr₹26 Cr₹11 Cr₹19 Cr₹18 Cr₹10 Cr₹4 Cr₹12 Cr₹15 Cr₹19 Cr₹12 Cr₹13 Cr₹12 Cr₹11 Cr₹7 Cr₹6 Cr₹12 Cr₹7 Cr₹5 Cr₹7 Cr₹5 Cr₹5 Cr₹8 Cr₹3 Cr₹6 Cr
₹32 L₹26 L₹27 L₹30 L₹23 L₹21 L₹37 L₹73 L₹35 L₹44 L₹50 L₹16 L₹39 L₹42 L₹1 Cr₹33 L₹14 L₹41 L₹57 L₹31 L₹20 L₹38 L₹58 L₹39 L-₹8 L₹67 L-₹56 L₹1 Cr₹58 L₹65 L₹79 L₹71 L₹2 Cr₹1 Cr₹94 L₹1 Cr₹1 Cr₹2 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹4 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹48 L₹1 Cr₹2 Cr₹1 Cr₹1 Cr
₹29 Cr₹48 Cr₹17 Cr₹35 Cr₹29 Cr₹35 Cr₹16 Cr₹29 Cr₹35 Cr₹29 Cr₹22 Cr₹38 Cr₹37 Cr₹25 Cr₹17 Cr₹31 Cr₹32 Cr₹21 Cr₹17 Cr₹24 Cr₹31 Cr₹25 Cr₹15 Cr₹18 Cr₹29 Cr₹21 Cr₹12 Cr₹13 Cr₹25 Cr₹18 Cr₹8 Cr₹11 Cr₹20 Cr₹23 Cr₹8 Cr₹16 Cr₹15 Cr₹7 Cr₹1 Cr₹9 Cr₹12 Cr₹15 Cr₹6 Cr₹10 Cr₹9 Cr₹8 Cr₹3 Cr₹4 Cr₹9 Cr₹4 Cr₹1 Cr₹4 Cr₹4 Cr₹3 Cr₹5 Cr₹1 Cr₹4 Cr
₹20 Cr₹36 Cr₹12 Cr₹29 Cr₹20 Cr₹28 Cr₹12 Cr₹21 Cr₹26 Cr₹24 Cr₹19 Cr₹28 Cr₹28 Cr₹19 Cr₹13 Cr₹22 Cr₹24 Cr₹15 Cr₹11 Cr₹18 Cr₹23 Cr₹18 Cr₹13 Cr₹13 Cr₹21 Cr₹15 Cr₹9 Cr₹11 Cr₹19 Cr₹13 Cr₹9 Cr₹9 Cr₹15 Cr₹16 Cr₹7 Cr₹12 Cr₹11 Cr₹5 Cr₹1 Cr₹7 Cr₹9 Cr₹11 Cr₹4 Cr₹6 Cr₹7 Cr₹7 Cr₹2 Cr₹3 Cr₹7 Cr₹3 Cr₹77 L₹3 Cr₹3 Cr₹3 Cr₹5 Cr₹1 Cr₹3 Cr

Share Price Live Stats

Open (₹)498.00
Volume (₹)2,563.00
High (₹)503.95
Upper Circuit605.20
Low (₹)498.00
Lower Circuit403.50
Prev Close504.35
52W High (₹)770.00
Price502.95
52W Low (₹)440.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)1010.40 Cr
Div. Yield (%)0.36
PE Ratio10.43
Debt to Equity0.01
Price to Book1.49
Book Value378.25
EPS (TTM)48.38
Face Value10.00
ROE (%)12.30

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
LINCOLNNSE
LTP
1W Low
1W High
Market cap (₹)
1789.1+11.4 (0.64%)
1722
1796.60
4,25,150Cr
9977+197 (2.01%)
9863
10067
2,66,265Cr
4632.5+19.1 (0.41%)
4553
4675
1,76,301Cr
2304.1-101.4 (-4.22%)
2252.40
2441.90
1,25,352Cr
1259.7+14.2 (1.14%)
1217.20
1261
1,23,591Cr
1373.2+21.2 (1.57%)
1336.70
1376.70
1,14,351Cr
1395.1+16.2 (1.17%)
1364.60
1400.80
1,12,474Cr
2506.5+13.7 (0.55%)
2457.90
2512.30
1,02,315Cr
1697.3+15.9 (0.95%)
1656.20
1708.80
97,757Cr
2050.7+39.7 (1.97%)
1988.90
2062.10
92,007Cr
502.95+3.65 (0.73%)
498
519
1,010Cr
Empty box

No content available